Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
The evolution of cystic fibrosis care
Jessica E. Pittman
, Thomas W. Ferkol
Institute of Clinical and Translational Sciences (ICTS)
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Division of Allergy & Pulmonary Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
51
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The evolution of cystic fibrosis care'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cystic Fibrosis
100%
Cystic Fibrosis Foundation
100%
Mucociliary Clearance
33%
Patient Care
16%
Illness
16%
Novel Therapies
16%
Gene Transcription
16%
Lung Disease
16%
Antimicrobial Therapy
16%
White People
16%
Physiological Changes
16%
Disease-causing mutations
16%
Genetic Interaction
16%
Environment Interaction
16%
Airway Obstruction
16%
Direct Therapy
16%
Personalized Therapy
16%
Airway Injury
16%
Channel Function
16%
Common Life
16%
Life-limiting
16%
Cystic Fibrosis Lung Disease
16%
Osmotic Agent
16%
New Antimicrobials
16%
Chronic Progressive
16%
Mucolytic Agents
16%
Medicine and Dentistry
Cystic Fibrosis
100%
Silo-Filler's Disease
33%
Mucociliary Clearance
33%
Diseases
33%
Infection
16%
Allele
16%
Personalized Medicine
16%
Patient with Cystic Fibrosis
16%
Genetic Transcription
16%
Antimicrobial Therapy
16%
Airway Obstruction
16%
Endotype
16%
Management of Cystic Fibrosis
16%
Mucolytic Agent
16%
Osmotic Agent
16%